Champions Oncology reports record Q2 revenue $11.8M, up 17% YoY; operating income $263K

CHAMPIONS ONCOLOGY, INC.

2022-Q2 EPS reported $0.01 revenue$23,039,000

Record quarterly revenue of $11.8M, up 17% from $10.1M year ago.
GAAP operating income of $263K vs. $7K a year ago; non-GAAP operating income $743K vs. $399K.
Gross margin improved to 52.4% from 44.2% due to reduced outsourcing.
Cash position $4.8M, no debt; net cash from ops $1.2M in quarter.
R&D investment increased 39.3% to $2.3M for therapeutic target discovery.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.